Revaxis
Revaxis is an originator product from Sanofi-Aventis (Suisse) SA and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 27.95 to CHF 27.95 depending on the pack; the patient co-payment is 10 per cent plus the deductible.
Core data
- Authorisation holder
- Sanofi-Aventis (Suisse) SA
- ATC code
- J07CA01
- IT group
- 08.08 Impfstoffe
- Active substances
- Toxoidum tetani, Toxoidum diphtheriae, Vaccinum poliomyelitidis inactivatum (Salk Typ I, II, III)
- Preparation type
- Originator product
- On the SL since
- 01/04/2001
- Last price change
- 01/12/2025
- Co-payment
- 10%
Prices per pack
The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.
| Dosage form | Pack size | Ex-factory price | Public price | Valid from | Cat. | GTIN |
|---|---|---|---|---|---|---|
| Inj Susp m Nadel | Fertspr 0.5 ml | CHF 10.60 | CHF 27.95 | 01/03/2025 | B | 7680006460034 |
Limitation
This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.
The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.
Die Preise der Impfstoffe sind Höchstpreise (Art. 52 Abs. 3 KVG) und kommen bei Reihenimpfungen (z.B. im schulärztlichen Dienst) nicht zur Anwendung. In diesen Fällen gelten die von den Krankenversicherern mit den zuständigen Behörden ausgehandelten bzw. die allenfalls von den Behörden festgesetzten Tarife. Wenn der Impfstoff zu einem günstigeren Preis bezogen wird (z.B. im Rahmen von Reihenimpfungen), darf der Arzt oder die Ärztin nicht den Publikumspreis der SL verrechnen.
Die Vergünstigung muss gemäss Artikel 56 Absatz 3 KVG weitergegeben werden, ausser es bestehen Vereinbarungen nach Artikel 56 Absatz 3bis KVG.
FAQ
Is Revaxis covered by Swiss health insurance?
Yes, but only under conditions. Revaxis is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.
What does Revaxis cost in Switzerland?
The public price is the maximum price set by the FOPH and for Revaxis ranges from CHF 27.95 to CHF 27.95 per pack. The ex-factory price ranges from CHF 10.60 to CHF 10.60. Pharmacies may not charge more, but may charge less.
Market access
Do you need your product on the Specialities List?
Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.
- Independent directory
- Official FOPH data
- Website in eight languages